Arcturus Therapeutics Holdings Inc.

ARCT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001768224

SEC filings (opens in a new tab)

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of ARCT: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	144	1	147	+4
Shares	23.6M	165	25.1M	+1.48M (+6.3%)
Value	$677.6M	$5.00K	$643.1M	−$34.4M (−5.1%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ARCT in Q3 2023
Institution	Shares	Value	% of portfolio
Granahan Investment Management Inc	398,862	$10.2M	0.36%
Portolan Capital Management, LLC	276,505	$7.06M	0.66%
Tri Locum Partners LP	208,886	$5.34M	1.71%
Jupiter Asset Management Ltd	194,781	$4.98M	0.06%
Schonfeld Strategic Advisors LLC	107,156	$2.74M	0.03%
SG Americas Securities, LLC	75,845	$1.94M	0.03%
Man Group plc	–	$1.40M	0.00%
Virtu Financial LLC	23,445	$599.0K	0.06%
SummerHaven Investment Management, LLC	22,326	$570.4K	0.42%
Blair William & Co	18,705	$477.9K	0.00%
Bank of Montreal	12,630	$372.8K	0.00%
Squarepoint Ops LLC	14,047	$358.9K	0.00%
LPL Financial LLC	14,011	$358.0K	0.00%
Robeco Institutional Asset Management B.V.	11,842	$302.6K	0.00%
Stratos Wealth Partners, LTD.	11,782	$301.0K	0.01%
Graham Capital Management, L.P.	8,546	$218.3K	0.01%
Vident Advisory, LLC	8,039	$205.4K	0.01%
New York State Teachers Retirement System	2,075	$53.0K	0.00%
Bessemer Group Inc	300	$8.00K	0.00%
Spire Wealth Management	310	$7.92K	0.00%
Global Wealth Strategies & Associates	100	$2.56K	0.00%
Comerica Bank	79	$2.02K	0.00%
Russell Investments Group, Ltd.	24	$613	0.00%

Sold out (19)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ARCT in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Arrowstreet Capital, Limited Partnership	127,244	$3.65M
Cubist Systematic Strategies, LLC	36,817	$1.06M
HRT Financial LP	23,377	$670.0K
Houlihan Financial Resource Group, Ltd.	21,700	$591.0K
Point72 Middle East FZE	19,838	$569.0K
Acadian Asset Management LLC	19,181	$548.0K
Globeflex Capital L P	18,047	$517.6K
Engineers Gate Manager LP	17,612	$505.1K
Corton Capital Inc.	16,074	$461.0K
Gotham Asset Management, LLC	12,029	$345.0K
Los Angeles Capital Management LLC	10,572	$303.2K
Alberta Investment Management Corp	9,602	$275.4K
E Fund Management Co., Ltd.	8,523	$244.0K
Delphia (USA) Inc.	8,287	$237.7K
Jump Financial, LLC	7,992	$229.2K
Quantbot Technologies LP	4,100	$117.6K
Headlands Technologies LLC	2,095	$60.1K
Northwestern Mutual Wealth Management Co	50	$1.43K
NewSquare Capital LLC	10	$287

Not filed for Q3 2023 yet (1)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARCT in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Endurance Wealth Management, Inc.	165	$5.00K